OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
August 11, 2022
Pharma Commerce's podcasts offer new angles on its roster of key topics
August 10, 2022
Given the biopharma sector‘s complex set of networks and supply chains, so it is not straightforward to shift towards net zero across all operations.
July 05, 2022
Dr. Frank Doyle, Dean of the Paulson School of Engineering and Applied Sciences at Harvard University, outlines his recommendations for Fortune 500 c-suites as they strive to attract, develop, and retain the best talent for their upcoming 2023 strategic plans.
June 10, 2022
A reflection on the industry's effort to foster and facilitate sustainability
May 25, 2022
EVERSANA CEO Jim Lang discusses the organization’s continuing rise in an industry that has seen seismic changes taking place
April 08, 2022
PC's new editor-in-chief details his thought process on familiarizing himself with a different side of the industry
It's time to include hubs in the patient treatment journey
March 29, 2022
How CDMOs will lead the way toward true cloud lab enablement
March 15, 2022
Harvard Business School Professor Amy C. Edmondson talks about achieving psychological safety in the workplace.
March 11, 2022
From supply-chain and clinical-trial disruptions in Ukraine and Russia, to decisions to halt investment or maintain operations, global implications for industry and pharmaceutical production are immense.